NCT00130507: Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab |
|
|
| Terminated | 2 | 14 | Europe | Vinorelbine, Navelbine, Capecitabine, Xeloda, Trastuzumab, Herceptin | Spanish Breast Cancer Research Group, Hoffmann-La Roche | Breast Cancer | 06/09 | 07/09 | | |
NCT01703910 / 2012-001307-20: Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic |
|
|
| Completed | 2 | 29 | Europe | Arm A chemotherapy, Capecitabine, Cisplatin, Cetuximab, Doxorubicin, Fluorouracil, Gemcitabine, Irinotecan, Topotecan, Mitomycin C, Oxaliplatin, Paclitaxel, Docetaxel, Pemetrexed, Raltitrexed, Sorafenib, Erlotinib, Vinorelbine, Dasatinib, Etoposide, arm B chemotherapy | Centro Nacional de Investigaciones Oncologicas CARLOS III, Hospital Universitario de Fuenlabrada, Grupo Hospital de Madrid, Apices Soluciones S.L. | Adenocarcinoma of Colon, Adenocarcinoma of Rectum, Metastatic Disease | 11/12 | 12/14 | | |
NCT01441596 / 2010-021415-16: Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases |
|
|
| Completed | 2 | 121 | US, Canada, Europe, RoW | Vinorelbine, Investigator's choice of treatment, afatinib | Boehringer Ingelheim | Breast Neoplasms, Neoplasm Metastasis | 02/14 | 08/14 | | |
NCT01305941: A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases |
|
|
| Completed | 2 | 32 | US | Everolimus, RAD001, Vinorelbine, Navelbine, Trastuzumab, Herceptin | UNC Lineberger Comprehensive Cancer Center, Novartis Pharmaceuticals | HER-2 Positive Breast Cancer | 08/16 | 10/17 | | |
